1887
  1. Home
  2. Eurosurveillance
  3. Volume 25, Issue 38, 24/Sep/2020
  4. Article
Perspective Open Access
Like 0
Download

Abstract

The World Health Organization (WHO) issued an updated position paper on rabies in 2018, mainly focusing on simplification of vaccination schedules and use of rabies immunoglobulin (RIG). The maximum amount of RIG anatomically feasible should be infiltrated exclusively in and around the wound and will no longer be calculated solely based on body weight. We describe the practical guideline implementing the revised RIG policy in the Netherlands on how to determine the amount of RIG for local administration. We calculated savings achieved through the revised WHO policy. We used information from a national database including rabies consultations in the Netherlands and clinical information from a public health service, clinical practitioners and national data on the amount of distributed RIG. Between 2008 and 2019, 5,164 consultations were registered. The most frequently affected anatomical location was hand or leg (43%). Around 80% concerned minor injuries (< 2 cm). From January 2016 to end December 2019, 7,361 mL RIG were distributed for 1,042 possible rabies exposures (EUR 1.4 million). Since implementing the revised policy, the amount of RIG distributed per order has sharply decreased (59%). Infiltrating RIG only locally saved large quantities of human RIG (EUR 1.1 million during 4 years) in the Netherlands.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.38.2000018
2020-09-24
2024-12-26
/content/10.2807/1560-7917.ES.2020.25.38.2000018
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/38/eurosurv-25-38-4.html?itemId=/content/10.2807/1560-7917.ES.2020.25.38.2000018&mimeType=html&fmt=ahah

References

  1. Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC. Current status of rabies and prospects for elimination. Lancet. 2014;384(9951):1389-99.  https://doi.org/10.1016/S0140-6736(13)62707-5  PMID: 24828901 
  2. World Health Organization (WHO). WHO expert consultation on rabies – third report. Geneva: WHO; 2018. Available from: https://apps.who.int/iris/handle/10665/272364
  3. Singh R, Singh KP, Cherian S, Saminathan M, Kapoor S, Manjunatha Reddy GB, et al. Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Vet Q. 2017;37(1):212-51.  https://doi.org/10.1080/01652176.2017.1343516  PMID: 28643547 
  4. Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9(4):e0003709.  https://doi.org/10.1371/journal.pntd.0003709  PMID: 25881058 
  5. Wieten RW, Tawil S, van Vugt M, Goorhuis A, Grobusch MP. Risk of rabies exposure among travellers. Neth J Med. 2015;73(5):219-26. PMID: 26087801 
  6. Carrara P, Parola P, Brouqui P, Gautret P. Imported human rabies cases worldwide, 1990-2012. PLoS Negl Trop Dis. 2013;7(5):e2209.  https://doi.org/10.1371/journal.pntd.0002209  PMID: 23658853 
  7. Shope RE. Rabies-related viruses. Yale J Biol Med. 1982;55(3-4):271-5. PMID: 6758373 
  8. Schneider LG. Antigenic variants of rabies virus. Comp Immunol Microbiol Infect Dis. 1982;5(1-3):101-7.  https://doi.org/10.1016/0147-9571(82)90021-2  PMID: 6181927 
  9. World Health Organization. Rabies vaccines: WHO position paper, April 2018 - Recommendations. Vaccine. 2018;36(37):5500-3.  https://doi.org/10.1016/j.vaccine.2018.06.061  PMID: 30107991 
  10. O’Brien KL, Nolan T, SAGE WG on Rabies. The WHO position on rabies immunization - 2018 updates. Vaccine. 2019;37(Suppl 1):A85-7.  https://doi.org/10.1016/j.vaccine.2018.10.014  PMID: 30342901 
  11. Centre for Infectious Diseases Control. Rabies guideline [in Dutch]. Bilthoven, The Netherlands: National Institute for Public Health and the Environment; 2018.
  12. Bharti OK, Thakur B, Rao R. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by "pooling strategy". Vaccine. 2019;37(Suppl 1):A128-31.  https://doi.org/10.1016/j.vaccine.2019.07.087  PMID: 31395454 
  13. Bharti OK, Madhusudana SN, Gaunta PL, Belludi AY. Local infiltration of rabies immunoglobulins without systemic intramuscular administration: An alternative cost effective approach for passive immunization against rabies. Hum Vaccin Immunother. 2016;12(3):837-42.  https://doi.org/10.1080/21645515.2015.1085142  PMID: 26317441 
  14. Bharti OK, Madhusudana SN, Wilde H. Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG. Hum Vaccin Immunother. 2017;13(4):762-5.  https://doi.org/10.1080/21645515.2016.1255834  PMID: 28277089 
  15. Soentjens P, Declercq S. Prophylaxie post-exposition contre la rage. [Rabies post-exposure prophylaxis]. Antwerp: Institute of Tropical Medicine; 2019. p. 16. French. Available from: https://www.itg.be/Files/docs/Reisgeneeskunde/PEP_Rabies_FR.pdf
Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Imke+Schreuder&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schreuder Imke</a>, <a href="/search?value1=Cornelis+De+Pijper&option1=author&noRedirect=true" class="nonDisambigAuthorLink">De Pijper Cornelis</a>, <a href="/search?value1=Rob+van+Kessel&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Kessel Rob</a>, <a href="/search?value1=Leo+Visser&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Visser Leo</a>, <a href="/search?value1=Hans+van+den+Kerkhof&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van den Kerkhof Hans</a>, <a href="/search?value1=on+behalf+of+the+Dutch+advisory+committee+on+rabies&option1=author&noRedirect=true" class="nonDisambigAuthorLink">on behalf of the Dutch advisory committee on rabies</a></span>. Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings. <a href="/content/ecdc">Euro Surveill.</a> 2020;25(38):pii=2000018. <a href="https://doi.org/10.2807/1560-7917.ES.2020.25.38.2000018" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2020.25.38.2000018</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 07 Jan 2020;&nbsp;&nbsp; <span class="generated">Accepted</span>: 16 Jul 2020 </span> </p>
/content/10.2807/1560-7917.ES.2020.25.38.2000018
/content/10.2807/1560-7917.ES.2020.25.38.2000018
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error